DIVERGING EFFECTS OF SILDENAFIL ON VENTRICULAR-VASCULAR FUNCTION IN HFPEF
Barry A. Borlaug(Mayo Clinic), Margaret M. Redfield(Mayo Clinic in Arizona), Kenneth B. Margulies(Temple University), Horng Chen(Mayo Clinic), Kevin Anstrom(PragmatIC (United Kingdom)), Gregory D. Lewis(Brigham and Women's Hospital), Eric J. Velazquez(Yale University), Grace Lin(Mayo Clinic), Steven E. McNulty, Martin M. LeWinter(University of Vermont Medical Center), Marc J. Semigran(Healthwise), Monica Shah(Clinical Research Institute)
Cited by 1
Related Papers
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
|New England Journal of Medicine|2004|1.9k
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
|Circulation Heart Failure|2010|1.1k
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
|European Heart Journal|2010|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877